Radiotherapy regimens and concurrent Cabergoline use for non-functioning pituitary neuroendocrine tumors: a large, single-center cohort

Key Points

• Cabergoline use alongside radiotherapy may improve outcomes for pituitary tumors.
• In a single-center cohort of non-functioning pituitary neuroendocrine tumors, cabergoline showed positive effects.
• Analysis focused on various radiotherapy regimens and their efficacy related to cabergoline.
• Findings highlight the need for further studies on combined treatment strategies for pituitary tumors.